U.S. Food And Drug Administration (FDA)

An analysis of the necessity for escort requirements in abortion care, tamoxifen to help with bleeding for implant users, depression and its possible correlation with unintended pregnancy, methods for remote gestational age assessment, and more.

Novel ulipristal-releasing copper IUD, internal medicine physicians’ provision of medication abortion in a primary care setting, analysis of contraceptive decision aids for adolescents and young adults, and more.

A new lower dose estrogen patch is now available!

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Honest answers—supported by facts and research—and patient resources too!

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.

Used only when needed, Phexxi changes the vaginal pH in the presence of semen to prevent pregnancy.